Ignite Creation Date:
2024-05-06 @ 3:16 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04575935
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2020-09-08
Brief Title:
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian Primary Peritoneal or Fallopian Tube Cancer LANCE Trial
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IVB Primary Peritoneal Cancer AJCC v8 |
| Advanced Ovarian Carcinoma |
| Fallopian Tube Clear Cell Adenocarcinoma |
| Fallopian Tube Endometrioid Tumor |
| Fallopian Tube Serous Neoplasm |
| Fallopian Tube Transitional Cell Carcinoma |
| Ovarian Clear Cell Adenocarcinoma |
| Ovarian Endometrioid Adenocarcinoma |
| Ovarian Serous Adenocarcinoma |
| Ovarian Transitional Cell Carcinoma |
| Primary Peritoneal Clear Cell Adenocarcinoma |
| Primary Peritoneal Endometrioid Adenocarcinoma |
| Primary Peritoneal Serous Adenocarcinoma |
| Primary Peritoneal Transitional Cell Carcinoma |
| Stage IIIC Fallopian Tube Cancer AJCC v8 |
| Stage IIIC Ovarian Cancer AJCC v8 |
| Stage IIIC Primary Peritoneal Cancer AJCC v8 |
| Stage IV Fallopian Tube Cancer AJCC v8 |
| Stage IV Ovarian Cancer AJCC v8 |
| Stage IV Primary Peritoneal Cancer AJCC v8 |
| Stage IVA Fallopian Tube Cancer AJCC v8 |
| Stage IVA Ovarian Cancer AJCC v8 |
| Stage IVA Primary Peritoneal Cancer AJCC v8 |
| Stage IVB Fallopian Tube Cancer AJCC v8 |
| Stage IVB Ovarian Cancer AJCC v8 |
Keywords: